Biospecimen Collection (NCT07293403)

Name: Biospecimen Collection trial for Follicular Helper T-Cell Lymphoma (NCT07293403)
Uploaded: 2026-10-31T22:09:20.161Z
Duration: 1 min 17 s
Description: Biospecimen Collection trial for Follicular Helper T-Cell Lymphoma (NCT07293403). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07293403.

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas: a one-minute explainerNCT072934031 min

Biospecimen Collection trial for Follicular Helper T-Cell Lymphoma (NCT07293403). This is a short film with English narration. The transcript is on this page, and the written brief is separate.

What the film says

Read the transcript

This trial is for adults with nodal T-follicular-helper lymphoma or peripheral T-cell lymphoma, not otherwise specified. A complete response after first-line CHOP-based chemotherapy within six months is required. Patients must decline or be ineligible for autologous transplantation.

The idea: take duvelisib twice daily to block growth signals in cancer cells. Treatment lasts up to one year; continued complete response can permit another 13 cycles. Researchers assess disease control. Screening includes bone-marrow biopsy.

This phase 2 study plans 25 patients. Christina Poh leads at City of Hope in Duarte, the sole recruiting US site.

Public record; not medical advice.

Read the full brief →

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.